Y. Abe, H. Urakami, D. Ostanin, G. Zibari, T. Hayashida et al., « Induction of Foxp3-Expressing Regulatory T-Cells by Donor Blood Transfusion Is Required for Tolerance to Rat Liver Allografts, PLoS ONE, vol.4, issue.11, 2009.

A. De and L. Biomédecine, Guide du Score Coeur, p.30, 2017.

A. V. Ambardekar, S. Kendall, A. N. Hunter, R. M. Babu, R. Tuder et al., Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study, vol.8, pp.944-952, 2015.

D. Ansari, P. Höglund, B. Andersson, J. Et, and . Nilsson, « Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis », Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol.5, issue.1, 2015.

G. J. Arnaoutakis, T. J. George, A. Kilic, E. S. Weiss, S. D. Russell et al., « Effect of Sensitization in US Heart Transplant Recipients Bridged with a Ventricular Assist Device: Update in a Modern Cohort, The Journal of Thoracic and Cardiovascular Surgery, vol.142, issue.5, pp.1236-1245, 2011.

J. L. Babitt, Y. Herbert, and . Lin, « Mechanisms of Anemia in CKD », Journal of the American Society of Nephrology, vol.23, issue.10, pp.1631-1634, 2012.

F. M. Bengel, N. Peter-ueberfuhr, S. G. Schiepel, B. Nekolla, and . Reichart, « Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation », New England Journal of Medicine, vol.345, issue.10, pp.731-738, 2001.

M. A. Brisco, E. Stephen, S. G. Kimmel, M. E. Coca, M. Putt et al., « Prevalence and Prognostic Importance of Changes in Renal Function after Mechanical Circulatory Support, Circulation. Heart Failure, vol.7, issue.1, pp.68-75, 2014.

B. E. Burrell, Y. Nakayama, J. Xu, C. C. Brinkman, J. S. Et et al., « Treg Induction, Migration, and Function in Transplantation », Journal of Immunology, issue.10, p.4705, 1950.

M. Cipriani, V. D. Simone, L. D. Angelo, E. Perna, M. Lilliu et al., Ventricular Assist Devices for Heart Failure: A Focus on Patient Selection and Complications, vol.2014, pp.199-211, 2014.

A. Combes, « Indications de l'assistance circulatoire, Communications scientifiques MAPAR, 5 et 6 juin 2010, 2010.

S. Crow, D. Chen, C. Milano, W. Thomas, L. Joyce et al., Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients, vol.90, pp.1263-1269, 2010.

G. C. Cursack, G. María, . Crespo-leiro, J. María, J. Paniagua-martín et al., Chronic Anemia in Heart Transplant Patients: Prevalence, Risk Factors, and Prognostic Significance, vol.60, pp.1144-1150, 2007.

A. Dalton, D. Curtis, and C. I. Harrington, « Synergistic Effects of Azathioprine and Ultraviolet Light Detected by Sister Chromatid Exchange Analysis, Cancer Genetics and Cytogenetics, vol.45, issue.1, pp.93-99, 1990.

E. M. Defilippis, K. Lauren, A. R. Truby, R. C. Garan, K. Givens et al., « Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation, JACC. Heart Failure, vol.7, issue.3, pp.250-257, 2019.

R. Dorent and . Lepage, « Transplantation cardiaque -Le rejet aigu et les traitements immunosuppresseurs en, p.31, 2012.

S. G. Drakos, A. G. Kfoury, . Kotter, . Reid, . Se-clayson et al., , 2009.

H. Prior, Allosensitization And Left Ventricular Assist Device Type Affect Degree Of Post-Implantation HLA-Allosensitization ». The Journal of heart and lung transplantation : the official publication of the International Society for, Heart Transplantation, vol.28, issue.8, pp.838-842

G. Drobinski, J. Collet, S. Et, and . Varnous, « Atherosclerosis of cardiac transplants: physiopathology and treatment, Sang Thrombose Vaisseaux, vol.16, issue.10, pp.520-526, 2004.

F. Flaman, S. Zieroth, V. Rao, H. Ross, D. H. Et et al., , 2006.

, « Basiliximab versus Rabbit Anti-Thymocyte Globulin for Induction Therapy in Patients after Heart Transplantation ». The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for, Heart Transplantation, vol.25, issue.11, pp.1358-1362

P. Franchetti, M. Et, and . Grifantini, « Nucleoside and Non-Nucleoside IMP Dehydrogenase Inhibitors as Antitumor and Antiviral Agents », Current Medicinal Chemistry, vol.6, issue.7, pp.599-614, 1999.

R. Freeman, C. Koerner, . Clark, and . Halabicky, « Cardiac Transplant Postoperative Management and Care, vol.39, pp.214-226, 2016.

G. Fröhlich, R. Marcus, E. Kaspar, W. Frank, . Mathias et al., « Statins and the Risk of Cancer After Heart Transplantation, Circulation, vol.126, issue.4, pp.440-447, 2012.

A. Furukawa, S. A. Wisel, Q. Et, and . Tang, « Impact of immune-modulatory drugs on Treg, Transplantation, vol.100, issue.11, pp.2288-2300, 2016.

A. Gabet, A. Lamarche-vadel, F. Chin, Y. Juillière, C. De-peretti et al., « Mortalité due à l'insuffisance cardiaque en France, p.31, 2000.

R. Girlanda, « Complications of Post-Transplant Immunosuppression ». Regenerative Medicine and Tissue Engineering, 2013.

J. L. Grodin, H. Mark, M. Drazner, W. Dupont, D. O. Mullens et al., « A Disproportionate Elevation in Right Ventricular Filling Pressure, in Relation to Left Ventricular Filling Pressure, Is Associated with Renal Impairment and Increased Mortality in Advanced Decompensated Heart Failure, American Heart Journal, vol.169, issue.6, pp.806-812, 2015.

A. Grupper, H. Gewirtz, S. Et, and . Kushwaha, « Reinnervation Post-Heart Transplantation, European Heart Journal, vol.39, issue.20, pp.1799-1806, 2018.

M. Guba, M. Philipp-von-breitenbuch, G. Steinbauer, S. Koehl, M. Flegel et al., « Rapamycin Inhibits Primary and Metastatic Tumor Growth by Antiangiogenesis: Involvement of Vascular Endothelial Growth Factor », Nature Medicine, vol.8, issue.2, pp.128-135, 2002.

A. Guidon, R. Hullin, N. Yarol, P. Yerly, P. Meyer et al., « Aspects médicaux autour de la transplantation cardiaque en, et Stéphane Reverdin, vol.10, pp.1197-1203, 2014.

J. Guihaire, E. Flécher, C. Chabanne, and S. Schrepfer, « La maladie coronaire du greffon : une complication silencieuse après transplantation cardiaque, Chirurgie Thoracique et Cardio-vasculaire, vol.18, issue.1, pp.33-42, 2014.

S. A. Hunt and . Et-françois-haddad, « The Changing Face of, Heart Transplantation -ScienceDirect, vol.52, issue.8, pp.587-598, 2008.

C. A. Janeway, K. Murphy, P. Travers, M. Et, . Walport et al., , 2009.

R. John, K. Lietz, M. Schuster, Y. Naka, V. Rao et al., « Immunologic sensitization in recipients of left ventricular assist devices, The Journal of Thoracic and Cardiovascular Surgery, vol.125, issue.3, pp.578-591, 2003.

P. Jungers, T. Oualim, Z. Nguyen-khoa, . Massy, and . Et-g-london, « La cardioprotection: une composante essentielle du traitement de l'insuffisance rénale chronique dès le stade prédialytique, Néphrologie, vol.24, issue.2, pp.78-88, 2003.

M. Kamboj and . Et-amir-kazory, « Left Ventricular Assist Device and the Kidney: Getting to the Heart of the Matter », Blood Purification, pp.1-10, 2019.

S. V. Kaveri, J. Gregg, . Silverman, J. Et, and . Bayry, « Natural IgM in immune equilibrium and harnessing their therapeutic potential », Journal of Immunology, vol.188, issue.3, pp.939-945, 1950.

. Kihara, K. N. Shin'ichiro, L. Litwak, P. Nichols, M. V. Litwak et al., Smooth Muscle Cell Hypertrophy of Renal Cortex Arteries with Chronic Continuous Flow Left Ventricular Assist, vol.75, pp.178-183, 2003.

M. Kirsch, J. Mazzucotelli, J. Roussel, O. Bouchot, N. Joseph et al., et André Vincentelli, 2012.

, Survival after Biventricular Mechanical Circulatory Support: Does the Type of Device Matter?, The Journal of Heart and Lung Transplantation, vol.31, issue.5, pp.501-508

P. Klaus, G. Heine, C. Rasche, M. Et, and . Worm, « Low-Dose Anti-Thymocyte Globulin Inhibits Human B-Cell Differentiation into Antibody-Secreting Cells, Acta Dermato-Venereologica, vol.95, issue.6, pp.676-680, 2015.

B. Ko, S. Soo, A. G. Drakos, D. Kfoury, G. J. Hurst et al., « Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant, The Journal of Heart and Lung Transplantation, vol.35, issue.8, pp.1024-1030, 2016.

N. Komatsu, M. E. Mariotti-ferrandiz, Y. Wang, B. Malissen, H. Waldmann et al., Heterogeneity of Natural Foxp3+ T Cells: A Committed Regulatory T-Cell Lineage and an Uncommitted Minor Population Retaining Plasticity, vol.106, pp.1903-1908, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00407810

J. Krzesinski and . Dubois, « Anémie et risque cardio-vasculaire chez l'insuffisant rénal chronique Nouvelles données sur la cible en hémoglobine à atteindre », Rev Med Liege, vol.62, issue.5-6, pp.366-370, 2007.

C. S. Lam, E. Donal, E. Kraigher-krainer, and . Et-ramachandran-vasan, « Epidemiology and clinical course of heart failure with preserved ejection fraction, European Journal of Heart Failure, vol.13, issue.1, pp.18-28, 2011.

L. Ch and H. Et-kreis, « A Tribute to Jean Hamburger's Contribution to, Organ Transplantation ». American Journal of Transplantation, vol.10, issue.11, pp.2392-2395, 2010.

P. Litzler, H. Smail, V. Barbay, C. Nafeh, F. Bouchart et al., « Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A singlecentre experience, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, vol.45, issue.1, pp.55-60, 2013.

P. Lobo and . Isaac, Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease, vol.7, 0198.

G. London, Pathophysiology of Cardiovascular Damage in the Early Renal Population ». Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association -European Renal Association, p.16, 2001.

J. F. Martin, S. A. Justin, N. R. Perry, X. Jakhete, . Wang et al., « An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56(Bright) NK Cells », Journal of Immunology, vol.185, issue.2, pp.1311-1320, 1950.

T. Michel, A. Poli, A. Cuapio, B. Briquemont, G. Iserentant et al., « Human CD56bright NK Cells: An Update, vol.196, pp.2923-2931, 2016.

C. Montagnat-tatavin, Prise en charge des patients greffés cardiaques : analyse de besoins auprès des patients et des professionnels de santé », Th D Pharm, 2012.

J. Moulis and . Et-monique-batlaj-lovichi, Rôle du psychiatre dans la transplantation hépatique, vol.23, p.167, 2008.

A. J. Olyaei, M. Angelo, D. De-mattos, M. William, and . Bennett, , 1999.

, « Immunosuppressant-Induced Nephropathy ». Drug Safety, vol.21, issue.6, pp.471-488

C. Ootaki, M. Yamashita, Y. Ootaki, K. Kamohara, S. Weber et al., Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin-Angiotensin System, vol.136, pp.150-158, 2008.

F. D. Pagani, D. B. Dyke, S. Wright, R. Cody, and K. D. Aaronson, « Development of Anti-Major Histocompatibility Complex Class I or II Antibodies Following Left Ventricular Assist Device Implantation: Effects on Subsequent Allograft Rejection and Survival ». The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for, Heart Transplantation, vol.20, issue.6, pp.646-653, 2001.

S. Patel, K. Oh, T. Ogriki, D. Sims, J. Shin et al., Cessation of Continuous Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding After Heart Transplantation, vol.64, pp.191-195, 2018.

M. Ramelet, « Caracterisation de la reponse immunitaire dans 3 modèles in vivo de cancers traites par des inhibiteurs de checkpoints immunitaires, 2017.

A. Rauch, Protéolyse du facteur Willebrand et cardiopathies à forces de cisaillement élevées : nouvelles approches diagnostiques et thérapeutiques ». Université du droit et de la santé, 2014.

N. L. Reinsmoen, « Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation, Human Immunology, vol.74, issue.11, pp.1474-1477, 2013.

J. G. Rogers, D. Keith, A. J. Aaronson, S. D. Boyle, C. A. Russell et al., « Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients », Journal of the American College of Cardiology, vol.55, issue.17, pp.1826-1834, 2010.

S. E. Sandner, D. Zimpfer, P. Zrunek, D. Dunkler, H. Schima et al., , 2008.

, « Renal Function after Implantation of Continuous versus Pulsatile Flow Left Ventricular Assist Devices ». The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, vol.27, pp.469-473

T. Santolaria, « Induction de tolérance aux allogreffes d'organes solides par les lymphocytes t régulateurs CD4+ CD25+ FOXP3+, 2009.

E. G. Schmitt, C. B. Et, and . Williams, « Generation and Function of Induced Regulatory T Cells », Frontiers in Immunology, vol.4, p.152, 2013.

J. S. Schroeder, . Shao-zhou, E. L. Gao, S. A. Alderman, I. Hunt et al., « A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant Recipients, N Engl J Med, vol.328, issue.3, pp.164-170, 1993.

S. B. See, A. Pinsino, N. Kunimune, D. Onat, E. Hittesdorf et al., Natural Antibodies and Left Ventricular Assist Device Complications, vol.38, pp.248-249, 2019.

S. B. See, J. Kevin, P. J. Clerkin, F. Kennel, M. P. Zhang et al., « Ventricular Assist Device Elicits Serum Natural IgG That Correlates with the Development of Primary Graft Dysfunction Following Heart Transplantation ». The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for, Heart Transplantation, vol.36, issue.8, pp.862-870, 2017.

S. Selvam, . Nivedita, P. D. Et, and . James, « Angiodysplasia in von Willebrand disease: Understanding the clinical and basic science, Seminars in thrombosis and hemostasis, vol.43, issue.6, pp.572-580, 2017.

C. Seydoux, Insuffisance cardiaque: traitement médical et transplantation. 2 e éd. Médecine et Hygiène, 2005.

C. Shen, Y. Hu, L. Hu, M. Hung, T. Su et al., « The Risk of Cancer in Patients with Generalized Anxiety Disorder: A Nationwide Population-Based Study », PLoS ONE, vol.8, issue.2, 2013.

A. Siri, H. De-boysson, G. Et, and . Boursier, Actualité sur les lymphocytes T régulateurs CD4 + ». médecine/sciences, vol.28, pp.646-651, 2012.

B. Skori?, M. ?ike?, J. L. Ma?ek, ?. Bari?evi?, I. ?korak et al., « Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis, Croatian Medical Journal, vol.55, issue.6, pp.562-576, 2014.

R. D. Starke, F. Ferraro, K. E. Paschalaki, N. H. Dryden, A. J. Thomas et al., Endothelial von Willebrand Factor Regulates Angiogenesis, vol.117, pp.1071-1080, 2011.

R. J. Steffen, H. Eugene, N. G. Blackstone, E. G. Smedira, K. J. Soltesz et al., « Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation, The Annals of Thoracic Surgery, vol.104, issue.5, pp.1569-1576, 2017.

A. L. Szymczak-workman, J. Creg, D. A. Workman, and . Vignali, « Cutting edge: regulatory t cells do not require stimulation through their t cell receptor to suppress », Journal of immunology, vol.182, issue.9, pp.5188-5192, 1950.

A. Telerman, R. Amson, P. Demant, P. Et, and . Marrack, Jean Dausset, vol.31, pp.171-173, 1916.
URL : https://hal.archives-ouvertes.fr/hal-02412809

O. Thaunat and . Morelon, « Immunosuppression et cancers : effet pro-et antitumoral des traitements immunosuppresseurs, Le Courrier de la Translantation, vol.3, issue.2, pp.87-92, 2003.

R. C. Thurston, M. Rewak, D. Et-laura, and . Kubzansky, « An Anxious Heart: Anxiety and the Onset of Cardiovascular Diseases », Progress in Cardiovascular Diseases, vol.55, issue.6, pp.524-537, 2013.

J. E. Tisdale, D. A. Et, and . Miller, Drug-Induced Diseases: Prevention, Detection, and Management, Am J Pharm Educ, vol.70, issue.6, p.148, 2006.

J. Trochu, « Assistance circulatoire prolongée : retour à domicile et qualité de vie, Académie Nationale de Médecine, vol.198, issue.7, pp.1345-1351, 2014.

B. Vergès, « Diabète secondaire aux inhibiteurs mTOR, Médecine des Maladies Métaboliques, vol.9, pp.255-259, 2015.

M. J. Wilhelm, « Long-term outcome following heart transplantation: current perspective », Journal of Thoracic Disease, vol.7, issue.3, pp.549-551, 2015.

M. A. Witman, R. S. Garten, J. R. Gifford, H. J. Groot, J. D. Trinity et al., « Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility. » JACC, Heart Failure, vol.3, issue.9, pp.703-711, 2015.

F. Yazdchi, T. K. Rajab, D. Rinewalt, D. Loberman, P. Shekar et al., Comparison of Heart Transplant Outcomes between Recipients with Pulsatile-vs Continuous-Flow LVAD, pp.1-7, 2009.

P. Yerly, F. Mach, A. Kalangos, S. Rotman, L. V. Segesser et al., « Suivi du patient après transplantation cardiaque : monitoring et adaptation de l'immunosuppression, Rev Med Suisse, vol.5, pp.1214-1220, 2009.

Q. Zhang and E. F. Reed, « The Importance of Non-HLA Antibodies in Transplantation », Nature Reviews Nephrology, vol.12, issue.8, pp.484-495, 2016.

E. Zorn, « New Insights on Innate B cell immunity in transplantation, Xenotransplantation, vol.25, issue.3, 2018.

. Serment-de-galien,

, En aucun cas, je ne consentirai à utiliser mes connaissances et mon état pour corrompre les moeurs et favoriser les actes criminels

, Que les hommes m'accordent leur estime si je suis fidèle à mes promesses. Que je sois méprisé de mes Confrères si je manque à mes engagements